Immediate or watchful waiting for antibiotics in possible pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial compares starting antibiotics right away versus waiting for more test results in people on a breathing machine who may have pneumonia. The goal is to find out which approach works better without causing harm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on a breathing machine (ventilator) for more than 48 hours
- You are 18 years or older
- You have a new or worsening spot on your chest X-ray and at least two signs of infection (fever, high or low white blood cells, or thick mucus from your lungs)
- You or your family have agreed to participate, or an emergency process is used
- You do not have severe pneumonia needing blood pressure medicine or severe low oxygen
- You do not have a weak immune system from conditions like recent organ transplant, HIV, or long-term high-dose steroids
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
This trial tests whether a medicine called interferon gamma can improve outcomes in adults with a first episode of pneumonia that develops after being on a ventilator in the ICU. It is designed for specific ICU timing, infection severity, and immune marker levels, and it compares treatment on top of standard care.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
Hear when a new Ventilator-Associated Pneumonia (VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.